Xilio Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.779; its P/E ratio is -0.46; Xilio Therapeutics is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -16.75M	$ -19.36M	$ -22.65M	$ -22.48M	$ -20.21M
EBITDA	$ -16.29M	$ -18.86M	$ -22.15M	$ -21.99M	$ -19.73M
Net Income Common Stockholders	$ -16.75M	$ -19.36M	$ -22.65M	$ -22.47M	$ -19.79M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 59.80M	$ 75.40M	$ 93.30M	$ 120.39M	$ 139.14M
Total Assets	$ 77.84M	$ 92.38M	$ 111.50M	$ 139.16M	$ 157.41M
Total Debt	$ 14.39M	$ 16.81M	$ 18.11M	$ 19.94M	$ 20.10M
Net Debt	$ -45.41M	$ -58.59M	$ -75.19M	$ -100.45M	$ -119.05M
Total Liabilities	$ 25.34M	$ 24.98M	$ 26.71M	$ 33.52M	$ 31.12M
Stockholders Equity	$ 52.50M	$ 67.39M	$ 84.79M	$ 105.65M	$ 126.30M
Cash Flow	-
Free Cash Flow	$ -13.37M	$ -16.89M	$ -25.42M	$ -18.73M	$ -20.24M
Operating Cash Flow	$ -13.37M	$ -16.57M	$ -25.25M	$ -18.22M	$ -19.91M
Investing Cash Flow	-	$ -316.00K	$ -170.00K	$ -509.00K	$ -333.00K
Financing Cash Flow	$ -2.24M	$ -992.00K	$ -1.69M	$ -21.00K	$ -22.00K

Currency in USD

Xilio Therapeutics Earnings and Revenue History

Income Statement >

Xilio Therapeutics Debt to Assets

Balance Sheet >

Xilio Therapeutics Cash Flow

Cash Flow >

Xilio Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing